|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies显示文摘 | G. Schwartsmann L. P. DiLeone M. Horowitz D. Schunemann A. Cancella A. S. Pereira M. Richter F. Souza A. Brondani Rocha F. H. Souza P. Pohlmann G. Nucci | 2006 | Investigational New Drugs2006，，5： | 2 |
| 2 | PhaseⅡtrial of cisplatin plus decitabine,a new DNA hypomethylating agent,in patients with advanced squamous cell carcinoma of the cervix显示文摘 | Pohlmann P DiLeone LP Cancella AI | 2002 | Am J Clin Oncol2002，25，5： | 1 |
| 3 | Phase Ⅱ trial of cispahin plus decitabine,a new DNA hypomethylating agent,in patients with advanced squamous cell carcinoma of the cervix显示文摘 | Pohlmann P Dileone LP Cancella AI | 2002 | Am J Clin Oncol2002，25，5： | 1 |
| 4 | Phase Ⅱ trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix 显示文摘 | POHLMANN P DILEONE L P CANCELLA A I | 2002 | Am J Clin Oncol2002，25，5： | 1 |
| 5 | Phase Ⅱ trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix 显示文摘 | Pohlmann P Dileone LP Cancella AI | 2002 | AmJ Clin Oncol2002，25，5： | 1 |
| 6 | Phase II trial ofcisplatin plus decitabine, a new DNA hypomethylating agent, in patients withadvanced squamous cell carcinoma of the cervix显示文摘 | Pohlmann P DiLeone LP Cancella AI | 2002 | Am J ClinOncol2002，25，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员